WKPep®Mini-collatide
You are here: Home » Products » Anti-Wrinkle & Anti-Aging » WKPep®Mini-collatide

WKPep®Mini-collatide

WKPep®Mini-collatide (INCI name: Tripeptide-29) is a small-molecule peptide designed from high-frequency repeating fragments of collagen, enabling it to accurately replicate the core functional segments of native collagen. Through peptide-induction technology, these oligopeptides act as signaling molecules that initiate the endogenous "collagen production line," stimulating fibroblast activity and promoting de novo collagen synthesis. This targeted mechanism effectively enhances procollagen Iα1 expression, improves damaged cell viability, and significantly boosts skin elasticity—confirmed by both in vitro cellular assays and in vivo clinical testing. With a recommended ultra-low dosage of 0.005%–0.03%, WKPep®Mini-collatide offers formulators a highly potent and cost-effective active for anti-aging serums, creams, and repair formulations targeting collagen depletion and loss of firmness.
Availability:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
kakao sharing button
snapchat sharing button
telegram sharing button
sharethis sharing button

INCI Name

Tripeptide-29

CAS Number

2239-67-0

Appearance

White to yellowish powder

PH

4.0–6.0 (1 mg/ml, H₂O)

Recommended Dosage

0.005%–0.03%

Storage

Refrigerated (5±3°C), dry, and sealed.

Scientific Mechanism & Efficacy Data

WKPep®Mini-collatide functions as a biomimetic signaling peptide that binds to fibroblast surface receptors, activating intracellular pathways that upregulate procollagen gene transcription. In vitro studies confirmed that within the concentration range of 50–500 ppm, WKPep®Mini-collatide significantly increased Type I collagen content in human skin fibroblasts (HSF), achieving a maximum increase of 59.74% compared to the control group (###p < 0.001). Additionally, it demonstrated no cytotoxic effects on HSF cells across a wide concentration range (1–1000 ppm) and improved the viability of UVB-damaged cells, with statistically significant recovery at 50 ppm (*p < 0.05), 200 ppm (p < 0.01), and 500 ppm (*p < 0.001) versus the UVB-only group.

In a 14-day clinical study, 33 participants (aged 30–60, with baseline facial R-value < 0.65) applied an emulsion containing 200 ppm WKPep®Mini-collatide twice daily. Compared to the placebo group, the active group demonstrated significant improvements in skin elasticity: R2 (gross elasticity) increased by 14.54%, R7 (viscoelasticity) by 14.37%, and Q1 (resilience) by 14.63% (###p < 0.001). These multi-dimensional elasticity gains confirm that WKPep®Mini-collatide effectively restores biomechanical properties—reducing sagging and promoting a firmer, more youthful skin appearance. Its ultra-low effective dosage, combined with robust safety and clinical validation, positions WKPep®Mini-collatide as a powerful and versatile ingredient for premium anti-aging applications.

Previous: 
Next: 

Quick Links

Product Category

...

Contact Us

Landline: +86-755-8695-1192
Tel: +86-177-2759-4013
E-mail: sales@winkey-china.com
Headquarters & R&D Add: 24th Floor, Building D3, Phase 2, Nanshan Zhiyuan, Taoyuan Street, Nanshan District, Shenzhen
Copyright © 2026 Winkey Technology Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy